about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma...
Read More
1.10
0.04
(3.77%)
2,642.4
XNAS Volume
XNAS 22 Sep, 2026 10:11 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..